Resource

Joint letter to FDA re: temporary flexibility in certain food labeling

Sign-on letter requests online allergen notification

ShareThis

The FDA has released guidance relaxing certain food labeling requirements for industry in the context of the pandemic. We recommend that the FDA require a manufacturer that makes any substitution to simply put a statement detailing the change in ingredient(s) on their website, including date and lot information, to allow food allergic consumers to confirm if a product is still “safe.” CSPI signed this letter along with the following groups:

  • Asthma and Allergy Foundation of America
  • Allergy Advocacy Association
  • Allergy & Asthma Network
  • AllergyStrong
  • American Partnership for Eosinophilic Disorders (APFED)
  • Center for Science in the Public Interest
  • CURED Nfp
  • E.A.T (End Allergies Together, Inc.)
  • Elijah-Alavi Foundation